191 related articles for article (PubMed ID: 18838215)
1. Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide.
Oh S; Kim BJ; Singh NP; Lai H; Sasaki T
Cancer Lett; 2009 Feb; 274(1):33-9. PubMed ID: 18838215
[TBL] [Abstract][Full Text] [Related]
2. Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis.
Nakase I; Gallis B; Takatani-Nakase T; Oh S; Lacoste E; Singh NP; Goodlett DR; Tanaka S; Futaki S; Lai H; Sasaki T
Cancer Lett; 2009 Feb; 274(2):290-8. PubMed ID: 19006645
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Efficacy of Artemisinin Loaded in Transferrin-Conjugated Liposomes versus Stealth Liposomes against HCT-8 Colon Cancer Cells.
Leto I; Coronnello M; Righeschi C; Bergonzi MC; Mini E; Bilia AR
ChemMedChem; 2016 Aug; 11(16):1745-51. PubMed ID: 26999297
[TBL] [Abstract][Full Text] [Related]
4. Effects of artemisinin-tagged holotransferrin on cancer cells.
Lai H; Sasaki T; Singh NP; Messay A
Life Sci; 2005 Jan; 76(11):1267-79. PubMed ID: 15642597
[TBL] [Abstract][Full Text] [Related]
5. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation.
Nakase I; Lai H; Singh NP; Sasaki T
Int J Pharm; 2008 Apr; 354(1-2):28-33. PubMed ID: 17942255
[TBL] [Abstract][Full Text] [Related]
6. Artemisinin-transferrin conjugate retards growth of breast tumors in the rat.
Lai H; Nakase I; Lacoste E; Singh NP; Sasaki T
Anticancer Res; 2009 Oct; 29(10):3807-10. PubMed ID: 19846912
[TBL] [Abstract][Full Text] [Related]
7. Discovery of artemisinin-glycolipid hybrids as anti-oral cancer agents.
Ricci J; Kim M; Chung WY; Park KK; Jung M
Chem Pharm Bull (Tokyo); 2011; 59(12):1471-5. PubMed ID: 22130368
[TBL] [Abstract][Full Text] [Related]
8. Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds.
Lai H; Sasaki T; Singh NP
Expert Opin Ther Targets; 2005 Oct; 9(5):995-1007. PubMed ID: 16185154
[TBL] [Abstract][Full Text] [Related]
9. Development of a dihydroartemisinin-resistant Molt-4 leukemia cell line.
Park J; Lai HC; Singh M; Sasaki T; Singh NP
Anticancer Res; 2014 Jun; 34(6):2807-10. PubMed ID: 24922643
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and in vitro efficacy of magnetic nanoliposomes containing the artemisinin and transferrin.
Gharib A; Faezizadeh Z; Mesbah-Namin SA; Saravani R
Daru; 2014 May; 22(1):44. PubMed ID: 24887240
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of ethanolic extracts of Artemisia annua to Molt-4 human leukemia cells.
Singh NP; Ferreira JF; Park JS; Lai HC
Planta Med; 2011 Nov; 77(16):1788-93. PubMed ID: 21674435
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisinin exerts its anticancer activity through depleting cellular iron via transferrin receptor-1.
Ba Q; Zhou N; Duan J; Chen T; Hao M; Yang X; Li J; Yin J; Chu R; Wang H
PLoS One; 2012; 7(8):e42703. PubMed ID: 22900042
[TBL] [Abstract][Full Text] [Related]
13. Artemisinin and its derivatives: a promising cancer therapy.
Kiani BH; Kayani WK; Khayam AU; Dilshad E; Ismail H; Mirza B
Mol Biol Rep; 2020 Aug; 47(8):6321-6336. PubMed ID: 32710388
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells.
Letis AS; Seo EJ; Nikolaropoulos SS; Efferth T; Giannis A; Fousteris MA
Bioorg Med Chem; 2017 Jul; 25(13):3357-3367. PubMed ID: 28456567
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of nοvel artemisinin dimers with polyamine linkers and evaluation of their potential as anticancer agents.
Magoulas GE; Tsigkou T; Skondra L; Lamprou M; Tsoukala P; Kokkinogouli V; Pantazaka E; Papaioannou D; Athanassopoulos CM; Papadimitriou E
Bioorg Med Chem; 2017 Jul; 25(14):3756-3767. PubMed ID: 28549888
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents.
Jung M; Lee K; Kim H; Park M
Curr Med Chem; 2004 May; 11(10):1265-84. PubMed ID: 15134519
[TBL] [Abstract][Full Text] [Related]
17. Biological Activities of Artemisinin Derivatives Beyond Malaria.
Liu X; Cao J; Huang G; Zhao Q; Shen J
Curr Top Med Chem; 2019; 19(3):205-222. PubMed ID: 30674260
[TBL] [Abstract][Full Text] [Related]
18. Holotransferrin enhances selective anticancer activity of artemisinin against human hepatocellular carcinoma cells.
Deng XR; Liu ZX; Liu F; Pan L; Yu HP; Jiang JP; Zhang JJ; Liu L; Yu J
J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):862-865. PubMed ID: 24337849
[TBL] [Abstract][Full Text] [Related]
19. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction.
Buragohain P; Saikia B; Surineni N; Barua NC; Saxena AK; Suri N
Bioorg Med Chem Lett; 2014 Jan; 24(1):237-9. PubMed ID: 24332623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
